Your Health, We Care
Capmatinib produced by Lucius Pharmaceuticals is available in the specification of 200 mg × 60 tablets.
The price of capmatinib may be affected by factors such as exchange rates, transportation costs and production costs.
Capmatinib is an antineoplastic agent (cancer medication). It works by interferi···【more】
Release date：2026-01-09Recommended：25
Capmatinib is indicated for the treatment of metastatic (spread) non-small cell ···【more】
Release date：2026-01-09Recommended：29
Capmatinib is a targeted therapy for patients with non-small cell lung cancer wi···【more】
Release date：2024-08-06Recommended：260
Capmatinib is an oral drug manufactured by Novartis Pharmaceutical. It is a tyro···【more】
Release date：2024-08-06Recommended：231
Capmatinib inhibits the growth of cancer cells caused by specific genetic varian···【more】
Release date：2024-08-06Recommended：240
